Skip to main content
PLOS ONE logoLink to PLOS ONE
. 2017 Jul 5;12(7):e0179783. doi: 10.1371/journal.pone.0179783

miR-182 aids in receptive endometrium development in dairy goats by down-regulating PTN expression

Lei Zhang 1, Xiaorui Liu 1, Junze Liu 1, Zhanqin Zhou 1, Yuxuan Song 1, Binyun Cao 1,*, Xiaopeng An 1,*
Editor: Bin He2
PMCID: PMC5497977  PMID: 28678802

Abstract

Increasing evidence has shown that miRNAs play important roles in endometrium development during the menstrual cycle in humans and many other animals. Our previous data indicated that miR-182 levels increase 15.55-fold and pleiotrophin (PTN) levels decrease 20.97-fold in the receptive endometrium (RE, D15) compared with the pre-receptive endometrium (PE, D5) in dairy goats. The present study shows that miR-182 is widely expressed in different tissues of dairy goats and that its expression levels are regulated by E2 and P4 in endometrial epithelium cells (EECs). We confirmed that PTN is a target of miR-182 and that miR-182 regulates the protein levels of AKT, Bcl-2, FAS, MAPK, Caspase-3 and SP1 in EECs. Furthermore, miR-182 up-regulates or maintains the expression levels of osteopontin (OPN), cyclooxygenase-2 (COX-2) and prolactin receptor (PRLR) in EECs, suggesting that miR-182 is an important regulatory factor in the construction of endometrial receptivity in dairy goats. In conclusion, miR-182 participates in the development of endometrial receptivity by down-regulating PTN and affecting the expression of select apoptosis-related genes and increasing or maintaining the expression levels of OPN, COX-2 and PRLR in the EECs of dairy goats.

Introduction

The endometrium is lined by epithelial cells (EEC) and is supported by a stromal cell (ESC) foundation [1]. The EEC layer is essential for reproductive success, including nutrition supply for embryo implantation and pregnancy maintenance [2, 3]. Endometrial receptivity is the result of both the synchronized and integrated interaction among many factors, and the reconstruction of the endometrium that allows for embryo adhesion [4]. Timing of implantation and endometrial receptivity have major impact on the establishment of a successful pregnancy and on the future health of offspring [5]. Although many factors participate in the development and progression of endometrial receptivity, the underlying molecular mechanisms are not very clear. Therefore, a better understanding of the development of endometrial receptivity, reproductive function and fecundity of animals is urgent.

In recent years, many miRNAs had been identified in the endometria of human [68] and mice [9]. Further studies reported that miR-30b, miR-30d, and -miR-494 are differentially expressed in pre-receptive and receptive endometria in human [10], suggesting that miRNAs played important roles in gene reprogramming during the formation of endometrial receptivity. In addition, miR-145 suppresses embryo-epithelial juxtacrine communication in the procession of embryo attachment by modulating the expression levels of IGF1R in endometria during WOI [11]. Together with its family members (miR-96 and miR-183), miR-182 was described in mouse neurosensory cells, specifically in the retina, inner ear, and dorsal root ganglia [1214]. Several studies have reported that miR-182 up-regulated in various cancer types, including prostate cancer [15, 16], glioblastoma [12], hepatocellular carcinoma [17]. What’s more, miR-182 could promote cellular differentiation by regulating the expression of snail family transcriptional repressor 2 (SNAI2) and induce the mesenchymal-to-epithelial transition [18]. The present study shows that miR-182 is widely expressed in different tissues in dairy goats, and the levels vary in association with the concentrations of E2 and P4 in EECs. To explore the role of miR-182 in EECs, miR-182 mimics and inhibitors were used to perform miR-182 overexpression or knockdown, respectively. Furthermore, EECs treated with a miR-182 inhibitors became round, the microvilli on the surface of the cell membrane disappeared, and the cell membrane sprouted and formed apoptotic bodies. Apoptosis, or the highly orchestrated form of programmed cell death in which cells neatly commit suicide without triggering an inflammatory response in the tissue, is becoming a relevant event in the study of reproductive physiology [19]. Thus, cell proliferation, cell cycle and apoptosis events of EECs were also analyzed after treatment with a miR-182 mimics or inhibitors.

PTN (also called HBGF8), an 18-kDa heparin-binding growth factor, shares 50% sequence homology with midkine [2023]. It is a secreted cytokines [24] that plays roles in diverse biology process, such as cell adhesion, migration, survival, growth, and differentiation [20, 22, 25]. Further study showed abnormalities on reproduction and development were observed in the PTN-KO mice [26]. What’s more, PTN was stimulated by pregnancy, displayed a higher expression in the caruncular (C) areas over the intercaruncular (IC) areas in bovine [27], and it increased in murine implantation sites during decidualization [28]. Considering the fact that PTN mainly expressed in the C areas of bovine endometrium, it may participate in the proliferation of stroma cells, and in the decidualization-like process [29] in dairy goats.

Our previous sequencing data indicated that miR-182 expression was increased 15.55-fold in the receptive endometrium (RE, D15) compared with the pre-receptive endometrium (PE, D5) in dairy goats [30], and its predicted target gene, PTN, was down-regulated 20.97-fold [31]. Thus, we inferred that miR-182 may participate in regulating dynamic changes in goat uterine gene expression patterns via down-regulated PTN. After confirming the increase of miR-182 and the low abundance of PTN mRNA in the RE of healthy multiparous dairy goats, the psiCHECKTM-2 reporter plasmid, RT-qPCR, and Western blotting (WB) were used to confirm that miR-182 down-regulated the expression of PTN in EECs of dairy goats. Furthermore, the protein levels of Bcl-2, FAS, MAPK, Caspase-3, SP1, and other marker genes of endometrial receptivity (OPN, VEGF, COX-2, PRLR) were analyzed in EECs that were treated with a miR-182 mimics or inhibitors.

Materials and methods

Ethics statement

All animals in this study were maintained according to the No. 5 proclamation of the Ministry of Agriculture, P. R. China. And animal protocols were approved by the Review Committee for the Use of Animal Subjects of Northwest A&F University.

Goats were euthanized when the goats lost consciousness caused by intravenous injection of barbiturate (30mg/kg). Endometrium samples from 5 goats at gestational day 5 and 5 goats at gestational day 15 were obtained from the anterior wall of the uterine cavity [30, 32]. Tissues were fixed in 10% formaldehyde in phosphate-buffered saline (PBS) for immunohistochemical studies; tissues were fixed in 2.5% Glutaraldehyde for Scanning Electron Microscopy (SEM); Another tissues were fixed in 4% paraformaldehyde for Immunohistochemistry (IHC).

Primary cell cultures

Primary dairy goat endometrial epithelial cells (EECs) were isolated and purified with the methods of trypsin enzymic digestion, differential centrifugation and differential attachment, and then the cells were observed and identified by light microscope [1, 33]. Briefly, immediately after the goats were euthanized, the uterus was placed into PBS supplemented with penicillin (100 IU/mL) and streptomycin (50 mg/mL), and then was transported to the laboratory within 2 h. The tissue was first washed with 75% alcohol for 1 min and then washed three times with PBS to eliminate alcohol. Endometrium was harvested from the uterus by sterile scalpel under sterile conditions, and then was incubated at 37°C in cell culture dish with 5-mL 0.25% trypsin for approximately 2 h, fetal bovine serum (FBS) was added to terminate digestion. The mucus and undigested organization were removed from cells suspension by 150 μm screen, the EECs were centrifuged (500× g, 10 min), resuspended in DMEM/F12 containing 10% FBS (HyClone, Logan, UT, USA). To isolate stromal cells, the supernatant fluid was centrifuged at 1000× g for 10 min, and then the stromal cell-rich fraction (supernatant fluid) was removed.

RNA extraction and RT-qPCR

Total RNA was extracted using Trizol reagent (TaKaRa, Dalian, China) following the manufacturer′s instructions. RT-qPCR was performed using the Bio-Rad CFX 96 Real Time Detection System and SYBR Green PCRMasterMix (TaKaRa, Dalian, China) in a 20 μl reaction according to the manufacturer′s instruction. All primers for the RT-qPCR are shown in Table 1, and the PCR products further identified by Sanger sequencing. The relative expression levels were calculated using the equation N = 2-ΔΔCt.

Table 1. The RT-qPCR Primers used in the present study.

gene GenBank
accession No.
Primer sequences
(5′→3′)
GADPH AF_030943.1 F: GCAAGTTCCACGGCACAG
R: GGTTCACGCCCATCACAA
PTN XM_005679509.1 F: TCTCCATTTCCCTTCCTTCC
R: TCTCTCTCCACTTCGGCTTT
PTN XM_005679509.1 F: GCCTCGAGGACCGTGAAAAGGACATC
R: GCGCGGCCGCCAGCATCACCTTGATTTA
18S / F: GTGGTGTTGAGGAAAGCAGACA
R: TGATCACACGTTCCACCTCATC
U6 / F: CTCGCTTCGGCAGCACA
R: AACGCTTCACGAATTTGCGT
miR-182-Loop / gtcgtatccagtgcagggtccgaggtattcgcactggatacgacAGTGTGAG
miR-182-FW / ggTGAAAAGTTCGTTCGG
Reverse Primer / GTGCAGGGTCCGAGGT

Note: the underscore characters were restriction enzyme cutting site of xho І and not І.

Cell transfection

A mature miR-182 mimics (5’-TTTGGCAATGGTAGAACTCACACT-3’) and inhibitors (5’-AGUGUGAGUUCUACCAUUGCCAAA-3’), a nonspecific control (NC) and NC-inhibitors were synthesized by GenePharma (Shanghai, China). EEC cells were plated at a density of 7.5×105 in 6-well plates, seventy percent confluent cells were transfected with miR-182, miR-182 inhibitors, NC, and NC-inhibitors at final concentrations of 100 nM using the X-tremeGENE siRNA Transfection Reagent (Roche, Switzerland) according to the manufacturer′s protocols. Stem-loop qPCR was used to detect the transfection efficiency of miR-182 in this study [34].

Analysis of cell proliferation, cycle and apoptosis

The methyl thiazolyl tetrazolium (MTT) (Sigma, St. Louis, MO, USA) colorimetric assay was used to evaluate the proliferation of EECs. Briefly, the cells were seeded in 96-well plates at a density of 2×103 cells/well; the cells were transfected with miR-182, miR-182 inhibitors, NC, and NC inhibitors, and then were incubated at 37°C in a 5% CO2 incubator for 24 h after the cells adhered to the plate; and then the MTT reagent (0.5 mg/mL) were added into 96-well plates and incubated for 4h. The relative number of viable cells, which is directly proportional to the production of formazan crystals solubilized by DMSO, the absorbance was measured at a wavelength of 490 nm as previously described [35].

To evaluate the mechanism of the cell growth deficiency in miR-182-transfected EEC, cell cycle staining Kit was used (Liankebio, Hangzhou, China) according to the manufacturer′s instruction. Cells were harvested 48 h later and washed three times by cold PBS, and then fixed in 70% ethanol in PBS at -20°C overnight. And then the cells were incubated with 0.5 ml of propidium iodide (PI) staining buffer, which contains 200 μg/ml RNase A and 50 μg/ml PI, at 37°C in the dark for 30 min [36]. Analyses were performed on BD LSR flow cytometer (BD Biosciences, San Diego, CA).

Cell apoptosis analysis was carried out using Annexin V-FITC/PI apoptosis kit [37] (Liankebio, Hangzhou, China) according to the manufacturer′s instructions. After being treated with miR-182 mimics or miR-182 inhibitors for 48 h, EEC cells were collected and incubated with Annexin V-FITC and PI at room temperature for 5 min in the dark. After adding 300 ml PBS to each sample, and cell apoptosis was detected with flow cytometer (BD Biosciences, San Diego, CA). Annexin-V-positive and PI-negative cells were defined as early apoptotic cells, and the late apoptotic cells were Annexin-V and PI positive cells.

Scanning Electron Microscopy (SEM)

The effect of miR-182 on the surface morphology of EEC was detected by SEM (Scanning Electron Microscopy) [38]. In short, glutaraldehyde-fixed (2.5%) samples were thoroughly washed with PBS buffer, dehydrated in graded ethanol, placed in 2% isoamyl alcohol for 3 hours, and underwent critical point drying. The samples were attached to the sample stage for observation with the surface (endometrial cavity surface) up and painted with silver conductive plastic using a vacuum coating apparatus for coating metal samples. Then, the samples were observed under the JSM-6330F SEM (JEOL, Japan).

Immunohistochemistry (IHC)

The paraformaldehyde-fixed (4%) samples were embedded with paraffin, and sectioned. And then the sections were deparaffinized in xylene and rehydrated followed by antigen retrieval in sodium citrate buffer for 10 min in a microwave oven at 100°C. Endogenous peroxidase was inhibited by incubation with 3% hydrogen peroxide for 10 min at RT, and then the sections were blocked in 10% normal goat serum for 30 min and incubated with a primary antibody (as be showed in Table 2) at 4°C overnight.

Table 2. The antibody used in the present study.

Name Manufacturer Product Number Species of the antigen Species of the antibody method for purification
β-Actin Beyotime, Shanghai, China AA128 Human Mouse AP
PTN Boster Co, Wuhan, China BA1369-2 Mouse Rabbit AP
AKT Beyotime, Shanghai, China AA326 Mouse Rabbit AP
p-AKT Beyotime, Shanghai, China AA331 Mouse Rabbit AP
Bcl-2 Beyotime, Shanghai, China AB112 Human Rabbit AP
FAS Abcam, Cambridge, U.K. ab82419 Mouse Rabbit AP
MAPK (p44/42) Beyotime, Shanghai, China AM076 Rat Rabbit AP
p-MAPK (p44/42) Beyotime, Shanghai, China AM071 Human Mouse AP
Caspase-3 (active form) Beyotime, Shanghai, China AC033 Human Rabbit AP
Sp1 Boster Co, Wuhan, China BA1402 Human Rabbit AP
OPN Boster Co, Wuhan, China BM0032 Human Mouse AP
VEGF Boster Co, Wuhan, China BA0407 Human Rabbit AP
LIF Boster Co, Wuhan, China BA1239-2 Rat Rabbit AP
PRLR Boster Co, Wuhan, China BA3818 Human Rabbit AP

Note: AP, affinity purification.

The tissue sections were incubated with a biotinylated secondary antibody for 30 min at 37°C. After washing for 10 min in TBS, the colour reaction was developed with the substrate diaminobenzidine (DAB; Zytomed Systems, Berlin, Germany) according to the manufacturer’s instructions. Finally the sections were washed under running tap water for 5 min, counterstained to haematoxylin (VWR, Carnaxide, Oeiras, Portugal). The relative density of the positive cells (density/area) in each slide was analyzed using Image-Pro Plus 6.0 Software (Media Cybernetics, USA)[39].

3′-UTR constructs/luciferase assay

We screened target genes for miR-182 using microRNA.org (http://www.microrna.org/). And the results showed that there was a target site for miR-182 in the 3′UTR PTN of mRNA. To generate reporter constructs for luciferase assays, the full-length 3′UTR of PTN were cloned and inserted downstream of the luciferase gene in the psiCHECKTM-2 vector (Promega, USA), and the mutated plasmid was constructed by inserting PTN 3′ UTR with mutated miR-182 binding site between the XhoI and NotI sites immediately downstream of the Renilla luciferase gene. The wild-type (psiCHECK-PTN-WT) or mutated (psiCHECK- PTN-UTR-Mut) plasmid was co-transfected with the miR-182 mimics or inhibitors into 293T cells.

HEK293T cells were plated in 24-well plates at 70% confluency. The adherent cells were cotransfected with 0.5 μg of luciferase reporter and miR-182 mimics, miR-182 inhibitors, NC, or NC inhibitors (100 nM). At 24h posttransfection, firefly (hluc+) and Renilla (hRluc) luciferase activities were measured with the Dual-Glo luciferase assay system according to the manufacturer′s instructions (Promega, USA) by a thermo scientific varioskan flash (Thermo scientific, USA), the hluc+ gene was used as reference gene to correct the variation of transfection efficiency, the relative luciferase activity was calculated as hRluc/hluc+. Experiments were performed three times in triplicate.

Protein extraction and Western blot analysis

Protein extraction was performed as described previously [40]. Briefly, cells were harvested and lysed in RIPA buffer (Roche Applied Science, Indianapolis, IN, USA). After 30 minutes′ standing at 4°C, centrifuged (11 000×g) for 10 min. Soluble protein in the supernatants was collected and total protein concentration was determined using the Bio-Rad DC Protein Assay, and then diluted with gel loading buffer (Beyotime, Shanghai, China) and boiled for 8 min.

Thirty micrograms of protein from each treatment was subjected to 12% SDS-polyacrylamide gel electrophoresis and transferred onto nitrocellulose membranes (Millipore, Bedford, MA, USA) at 100 V for 1.5 h in ice bath. Non-specific binding sites were blocked with 5% fat-free powdered milk (blocking solution) TBS-buffered saline plus Tween 20 [0.2% (vol/vol)] (TBST) at room temperature for 2 h. After three washes for 10 min each with TBST, membranes were incubated with primary antibodies (Table 2) overnight at 4°C. After this incubation, membranes were washed three times and then incubated at room temperature for 2 h with the horseradish peroxidases (HRP)-conjugated second antibody at 1:1000 dilutions. After three washes for 5 min each with TBST, proteins were detected using enhanced chemiluminescence (Advansta, California, USA). Quantification was performed using the Quantity One program (Bio-Rad, California, USA).

Statistical analysis

All the data were processed with SPSS 17.0 (SPSS Inc., Chicago, IL, USA). One-way ANOVA was used to compare the differences, and the method of the least significant difference (LSD) was used for further analysis, and the differences were considered significant when P was <0.05 and very significant when P was <0.01.

Result

The expression of miR-182 in dairy goats

Our previous study indicated that miR-182 was a differentially expressed miRNA and had a 15.55-fold increase in the receptive endometrium (RE) compared with the pre-receptive endometrium (PE) in dairy goats [30]. Therefore, we inferred that miR-182 may participate in regulating dynamic changes in goat uterine gene expression patterns that occur during the transition from the pre-receptive to the receptive phase. Total RNAs were extracted and stem-loop qRT-PCR was used to validate the expression levels of miR-182 compared with the 18S rRNA and U6 reference controls in the dairy goat endometrium. The results showed that miR-182 expression level in the RE was higher (Fig 1) than that in the PE using either reference, which was inconsistent with previous sequencing data.

Fig 1. Expression levels of miR-182 in endometrium at D5 and D15.

Fig 1

The miR-182 levels in endometrium at D5 and D15 were detected by stem-loop qRT-PCR, 18S rRNA (A) and U6 (B) were used as the references. The values were showed as “means ± SD” (n = 5×3), ** indicates that P < 0.01.

Furthermore, the expression levels of miR-182 in various tissues of dairy goats were studied, and miR-182 was found to be widely expressed in different tissues at both biophysical stages. The highest expression levels were observed in the kidney, followed (in order) by the hypothalamus, ovary, liver, lung, spleen, and oviduct at gestational day 5 (D5, PE), whereas at gestational day 15 (D15, RE), the highest levels were observed in the oviduct, followed (in order) by the hypothalamus, kidney, heart, lung, liver, spleen, and ovary (Fig 2). The liver showed the largest difference in miR-182 levels between D5 and D15; the level decreased 120.63-fold at D15 compared with that at D5 (P < 0.01). In addition, miR-182 levels decreased significantly in the oviduct but increased significantly in the ovary at D15 compared with D5 (P < 0.01).

Fig 2. miR-182 was expressed in various tissues of dairy goats.

Fig 2

The miR-182 levels in different tissues were measured by Stem-loop RT-qPCR and normalized to 18S. Values were showed as “means ± SD” in receptive endometrium (RE, D15) that were relative to pre-receptive endometrium (PE, D5); n = 5×3. ** indicates that P < 0.01 and * indicates that P < 0.05.

The effect of E2/P4 on the expression levels of miR-182 in EEC

To investigate the response of miR-182 expression levels on sex hormones in EECs, β-estradiol (E2) and progesterone (P4) were diluted in cell medium to different concentrations. The expression levels of miR-182 were significantly enhanced with the constituents of E2, and the highest level was 10 nM in this study. The highest level of miR-182 was observed after treatment with 1 nM P4. The miR-182 levels were down-regulated when the cells were treated with combination of E2 and P4 (Fig 3). This result suggested that the expression levels of miR-182 were affected by sex hormones in EECs.

Fig 3. The effect of E2 and P4 on the expression levels of miR-182 in endometrial epithelium cells (EECs).

Fig 3

The effect of E2 and P4 on the expression levels of miR-182 in EEC were measured by Stem-loop RT-qPCR and normalized to 18S. Values were showed as “means ± SD” (n = 3×3). * mean that the difference was significant compared to the control cells (did not added E2 and P4 in cell medium).

miR-182 affected the surface microtopography of EEC

Prior to the receptive phase in the uterus, the surface epithelium is characterized by a dense distribution of long, thin microvilli that are covered with a uniformly glycocalyx, are under hormonal control and vary in length and number with the estrous cycle and during pregnancy [41]. On the surface cells treated with mimics of miR-182, microridges with uniform and regularly distributed microvilli were observed. However, cells treated with miR-182 inhibitors became significantly shrinked and gradually became round shape with poorly adhesion (Fig 4).

Fig 4. The effect of miR-182 on the surface microtopography of endometrial epithelium cells (EECs).

Fig 4

The contours of miR-182 mimic-transfected EEC cells are clear and microvilli regularly distributed on the surface; after the EEC cells were transfected with miR-182 inhibitor, cells became significantly shrinked and gradually became round shape with poorly adhesion.

miR-182 regulated cell proliferation, cycle and apoptosis of EEC

In this study, MTT assay (3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyl-2-H-tetrazolium bromide) showed that miR-182 mimics inhibited cell proliferation and miR-182 inhibitors promoted cell proliferation, but the differences were not statistically significant in EEC cells (Fig 5). Cell proliferation is generally regulated by progression through the cell cycle [42]. Consequently, disruption of the cell cycle is considered the common cause behind the inhibition of cell proliferation [43]. To determine whether the anti-proliferative effect of miR-182 is due to cell cycle disruption, flow cytometry was used to analyze the changes in the cell cycle in EECs. The DNA contents of miR-182-treated or control NC cells were quantitated for cell cycle analysis. The distribution of cells in the different phases of the cell cycle did not significantly change following miR-182 exposure in EECs (Fig 6), suggesting that miR-182 did not cause EEC cell cycle arrest under the conditions described.

Fig 5. The effect of miR-182 on the proliferation of endometrial epithelium cells (EECs).

Fig 5

The effect of miR-182 on the proliferation of EEC was measured by MTT. Values were showed as “means ± SD” (n = 3×7). ** indicates that P < 0.01 and * indicates that P < 0.05.

Fig 6. The effect of miR-182 on the cell cycle of endometrial epithelium cells (EECs).

Fig 6

The cell cycle analysis of EEC were made after the cells were transfected with miR-182 mimic (A); NC (B); miR-182 inhibitor (C); NC inhibitor (D).

In addition, an Annexin V-FITC/PI assay combined with flow cytometry 48 h after transfection with miR-182 mimics or inhibitors, NC or NC- inhibitors showed increased apoptosis of EECs (Fig 7A–7D) upon treatment with the miR-182 mimics compared with NC. The apoptosis rate of EECs treated with the scrambled miR-182 mimics was 15.76%, and the apoptosis rate decreased to 7.59% when treated with the miR-182 inhibitors. This study suggested that miR-182 induced EECs apoptosis.

Fig 7. The effect of miR-182 on the cell apoptosis of endometrial epithelium cells (EECs).

Fig 7

The cell apoptosis analysis of EEC were made after the cells were transfected with miR-182 mimic (A); NC (B); miR-182 inhibitor (C); NC inhibitor (D).

PTN are differentially expressed in the pre-receptive and receptive endometrium

Constitutive expression of PTN in adults is limited to cells such as testicular Leydig cells, uterine cells, and discrete populations of glia and neurons [4447]. Hormones, such as estrogen and testosterone, are regulators of PTN gene expression [48], and a further study has shown that PTN is an IFNT-regulated gene in the glandular epithelial cells [27].

In the previous study, we adopted the Illumina Solexa technology to obtain a large and reliable transcriptomic dataset from the PE (D5) and RE (D15) in dairy goats. A comprehensive analysis of the mRNA was constructed, and PTN was found to be decreased 20.97-fold in the RE compared with the PE. In the present study, we also observed that the luminal and glandular epithelia, which are vascular endothelial and smooth muscle cells in the endometrium, respectively, displayed a strong cytoplasmic distribution pattern for PTN (Fig 8), and this PTN immunoreaction intensity (DOI) was lower at D15 compared with D5 (Table 3).

Fig 8. The expression levels of PTN protein in the endometrium at D5 and D15.

Fig 8

The protein levels were detected by Immunohistochemical staining in the endometrium at D5 and D15. LE, luminal epithelium; GE, glandular epithelium; SC, stroma cell; VE, vascular endothelial cell. Original magnification ×40 (A, D, ruler marker = 200 μm), ×100 (B, E, ruler marker = 80 μm), ×400 (C, F, ruler marker = 20 μm).

Table 3. The immunohistochemical staining results of PTN in uterus of dairy goats.

Index (Mean) 100× 400×
D5 D15 D5 D15
Area 118.37±5.6 115.19±10.34 626.15±10.85** 155.83±27.63
Density 0.28±0.02 0.24±0.13 0.28±0.02 0.28±0.02
IOD 34.54±1.67 31.33±4.01 192.68±33.85** 46.15±8.60

Note: IOD was integrated optical density.

“**”, p< 0.01.

miR-182 directly regulates PTN through its 3′ UTR

Human PTN was predicted to be the target of miR-182 based on the information from Targetscan (www.targetscan.org) and miRanda (www.microrna.org). Importantly, the predicted target site is also conserved, and miR-182 was found to directly target goat PTN through its 3′-UTR sequence. Therefore, we hypothesized that miR-182 down-regulates the expression of PTN in the endometrial cells of dairy goats.

To determine whether miR-182 directly targets goat PTN through the predicted binding sites in the PTN 3′ UTR, the full-length 3′ UTR-containing miR-182 targeted sites were cloned and inserted downstream of the luciferase gene in the psiCHECKTM-2 reporter plasmid, and the mutated plasmids were constructed by inserting PTN-3′ UTR with the mutated miR-182 binding site (Fig 9A and 9B). The wild-type (psiCHECK-PTN-UTR-WT) or mutated (psiCHECK-PTN-UTR-Mut) plasmids were co-transfected with either the miR-182 mimics, miR-182 inhibitors, NC, or NC-inhibitors into HEK293T cells. After co-transfection with the plasmids, the luciferase activity of the miR-182 group was significantly lower than that of the NC group (P < 0.01) after 48 h after transfection, and this reduction was rescued in the mutation groups (Fig 9C). These results confirm that miR-182 targets goat PTN.

Fig 9. miR-182 down-regulated the expression level of PTN via the 3′ UTR.

Fig 9

(A) Schematic diagram illustrating the design of luciferase reporters with the WT- PTN 3′ UTR (WT-PTN) or the site-directed mutant PTN 3′ UTR (Mut-PTN). The nucleotides in red represented “seed sequence” of miR-182, the mutation nucleotides were in yellow color. (B) psiCHECKTM-2 vector map and the insertion site of PTN-3′UTR marked in green color. (C) The PTN -3′ UTR or its mutation luciferase reporter vectors were co-transfected with miR-182 mimic (or negative control) into 293T cells. Luciferase assay was performed 24 h after transfection. Results are represented as relative luciferase activity. The results are represented as mean ± SD (n = 3×3); *p < 0.05, ** p < 0.01.

miR-182 regulates PTN expression in EECs

After confirming the high abundance of miR-182 and low levels of PTN mRNA in the RE of goats, we further investigated if miR-182 down-regulates the expression levels of PTN in EECs. We transfected EECs with a miR-182 mimics, miR-182 inhibitors, NC (negative control), or NC-inhibitors at a cell density of 80–90% using Lipofectamine 2000. The mRNA levels of PTN significantly decreased at both 24 h (P < 0.01) and 48 h (P < 0.05) after the EEC was transfected with the miR-182 mimics (Fig 10A). However, the miR-182 inhibitors had no effect on the mRNA expression levels at 24 h and 48 h (P > 0.05).

Fig 10. miR-182 down-regulated the PTN in endometrial epithelium cells (EECs).

Fig 10

(A) miR-182 down-regulated the PTN mRNA levels in EEC, PTN mRNA levels were measured by RT-qPCR and normalized to GAPDH. Values were showed as “means ± SD”, ** indicates that P < 0.01 and * indicates that P < 0.05. (B) PTN protein levels were measured by WB, PTN densitometry was normalized to the β-actin density from the same lane. Each experiment was repeated three times in triplicate, the results are represented as mean ± SD (n = 3×3); *p < 0.05. The date was analyzed only compared to its corresponding NC at the same timing.

We further quantified PTN protein expression by performing WB analysis. PTN protein levels were significantly decreased in miR-182-transfected cells compared with NC at both 48 h and 72 h (P < 0.05), and miR-182 inhibitors significantly increased PTN levels in EECs at 48 h (P < 0.01) but not at 72 h (P > 0.05).

miR-182 regulates AKT expression in EECs

AKT is the central node in the PTEN-regulated pathway, and activated AKT has been shown to promote cell cycle progression, cell growth, cell survival, cell migration, angiogenesis, protein synthesis, and glucose metabolism through phosphorylation of its substrates [49]. A recent study suggested that PTN plays a critical positive feedback role in controlling AKT activity [50]. The above results suggest that miR-182 regulates PTN expression in EECs, and we sought to analyze AKT protein levels after the cells were treated with miR-182. We found that miR-182 decreased the expression of total AKT protein levels both at 48 h (P < 0.05) and 72 h (P < 0.05), and the miR-182 inhibitors increased AKT levels at 72 h (P < 0.05, Fig 11A). Furthermore, miR-182 also decreased p-AKT protein levels at 48 h (P < 0.05), and the miR-182 inhibitors increased p-AKT levels at both 48 h (P < 0.05) and 72 h (P < 0.05, Fig 11B).

Fig 11. The effect of miR-182 on AKT and p-AKT levels in endometrial epithelium cells (EECs).

Fig 11

AKT protein levels (A) in EEC cells, p-AKT protein levels (B) were measured by WB, densitometry was normalized to the β-actin density from the same lane. Each experiment was repeated three times in triplicate, the results are represented as “means ± SD” (n = 3×3), ** indicates that P < 0.01 and * p < 0.05. The date was analyzed only compared to its corresponding NC at the same timing.

miR-182 regulates the expression of PTN-related genes

As a growth factor, PTN stimulates the mitogenesis of fibroblasts, endothelial cells, and epithelial cells in culture, as well as neurite outgrowth in neonatal neuronal cells [51, 52]. Homeostasis of endometrial tissue plays an important role in the preparation of the uterus for each new estrous cycle or to support pregnancy [41]. Previous studies have evaluated cell proliferation and apoptosis in the endometrium during the estrous cycle. Apoptosis of endometrial cells has been studied in sow [53], canine [54, 55], rabbit [56] and women [57]. However, to our knowledge, no such study has yet been undertaken in the dairy goat. Thus, the protein levels of Bcl-2, FAS, MAPK, Caspase-3, and SP1 were detected in the EECs treated with miR-182.

Previous studies have confirmed that the Bcl-2 family proteins are regulated during the involution of endometrium cells. Thus, we proposed that the expression of Bcl-2 family proteins may be altered under miR-182 conditions in EECs. Bcl-2 protein expression levels were decreased significantly 48 h after treatment with miR-182 mimics (P < 0.01) and 72 h (P < 0.05), and the levels were significantly up-regulated after the EECs were treated with the miR-182 inhibitors at 72 h (P < 0.05). Confusingly, miR-182 inhibitors down-regulated the protein expression level of Bcl-2 at 48 h (P < 0.01) (Fig 12A).

Fig 12. The effect of miR-182 on PTN-related protein levels in endometrial epithelium cells (EECs).

Fig 12

Bcl-2 (A), MAPK (B), p-MAPK (C), FAS (D), Caspase-3 (E), and SP1 (F) protein levels were measured by WB, densitometry was normalized to the β-actin density from the same lane. Each experiment was repeated three times in triplicate, the results are represented as “means ± SD” (n = 3×3), ** indicates that P < 0.01 and * p < 0.05. The date was analyzed only compared to its corresponding NC at the same timing.

Furthermore, the expression of proteins upstream of Bcl-2, MAPK (p44/42) and p-MAPK (p44/42), were quantified by WB analyses. The expression of total MAPK and p-MAPK proteins were detected, and these data showed that miR-182 decreased the MAPK protein levels in EECs at 72 h (Fig 12B). Surprisingly, both the miR-182 mimics and inhibitors increased the p-MAPK levels at 48 h (P < 0.01) and decreased at 72 h (P < 0.05, Fig 12C). The miR-182 mimics increased the protein expression levels of FAS in EECs at 48 h (P < 0.01) and 72 h (P < 0.05) (Fig 12D). The expression levels of FAS were not affected in miR-182 inhibitors-treated EECs at 48 h (P < 0.01).

The morphological alterations observed in different cells undergoing apoptosis were due to the activation of specific enzymes known as “Caspases”. The activation of these enzymes modulate apoptosis, and they serve as markers of apoptosis before morphological signs are evident [41]. Caspase-3 is a key protease involved in the execution of apoptosis. The miR-182 mimics increased the Caspase-3 protein levels at both 48 h (P < 0.05) and 72 h (P > 0.05) in EECs (Fig 12E).The miR-182 inhibitors decreased Caspase-3 levels at 48 h (P < 0.05) and 72 h (P < 0.05). Furthermore, the miR-182 mimics decreased SP1 protein levels at 48 h (P < 0.05) in EECs (Fig 12F), but the difference was not significant at 72 h (P > 0.05). In addition, miR-182 inhibitors did not affect SP1 protein levels at either the 48 h or 72 h time points in EECs.

miR-182 regulates the expression of endometrial receptivity marker genes

Endometrial receptivity is the result of the synchronized and integrated interaction between ovarian hormones, growth and transcription factors, lipid mediators, and cytokines with paracrine signaling [58], and rebuilds the phenotype that allows embryo adhesion and placentation to occur [59]. More recently, several morphological and biochemical endometrial receptivity biomarkers were proposed, including OPN [60], VEGF [61], COX-2 [62] and PRLR [63, 64] during the WOI [65]. Therefore, changes in OPN, VEGF, COX-2 and PRLR protein levels were investigated in EECs after they were treated with miR-182 mimics, miR-182 inhibitors, NC (negative control), or NC-inhibitors.

The OPN protein levels were up-regulated at both 48 h and 72 h (P < 0.05) in miR-182 mimics-treated EECs. In addition, miR-182 inhibitors decreased OPN levels at 48 h and 72 h (P < 0.05, Fig 13A). The miR-182 mimics decreased VEGF protein levels in EECs at 48 h (P < 0.05) but not at 72 h (P > 0.05), and the miR-182 inhibitors increased VEGF protein levels at 72 h but not 48 h (Fig 13B), suggesting that the miR-182 mimics and inhibitors exert their effects on different timelines.

Fig 13. The effect of miR-182 on some marker protein of endometrial receptivity in endometrial epithelium cells (EECs).

Fig 13

The protein levels of OPN (A), VEGF (B), COX-2 (C) and PRLR (D) were measured by WB, densitometry was normalized to the β-actin density from the same lane. Each experiment was repeated three times in triplicate, the results are represented as “means ± SD” (n = 3×3), ** indicates that P < 0.01 and * p < 0.05. The date was analyzed only compared to its corresponding NC at the same timing.

No statistical differences were found in COX-2 levels between the miR-182 mimics and NC in EECs at either 48 h or 72 h (P > 0.05), but COX-2 expression levels in the EECs were significantly decreased 48 h and 72 h after treatment with the miR-182 inhibitors compared with NC (P < 0.05). Furthermore, the miR-182 inhibitors decreased PRLR protein levels at 72 h (P < 0.05) in EECs (Fig 13D), but no significant difference in PRLR protein level was found with the mimics (P > 0.05).

Discussion

In recent years, more and more miRNAs have been recently identified and play important roles in post-transcriptional regulation of gene expression in the endometrium, such as miR-183 regulate ITGB1P expression and promote invasion of ESC cells [66]. Functional studies indicated that miR-183 might contribute to human endometrial stromal cell apoptosis and impose a negative regulatory impact on cell invasiveness in humans [67]. In addition, miR-21 is highly expressed in the sub-luminal ESC cells at implantation sites is regulated in active blastocysts in the mouse [68].

The expression of miR-182 in dairy goats

miR-182 was first identified as a retina-specific miRNA, with its expression abundantly increasing postnatally and reaching the peak in adult retina [14]. Further study showed that miR-182 displayed a diurnal variation in the retina of mice, revealed its role in retina development and the regulation of mammalian circadian rhythm [69]. What’s more, miR-182 is demonstrated to function either as a tumor suppressor or an oncomir in various human cancers [12, 17, 70]. Our previous sequencing data have indicated that miR-182 is a differentially expressed miRNA with a 15.55-fold increase in the RE compared with the PE of dairy goats [30]. In the present study, the expression level of miR-182 in the PE was remarkably higher than that in the RE (Fig 2), which was inconsistent with the previous sequencing data [30]. Furthermore, this study showed extensive expression of miR-182 in other tissues, especially in the kidney at D5 and oviduct at D15.

The effect of E2/P4 on the expression levels of miR-182 in EECs

E2 and P4 play leading roles in the endometrium of animals, and EECs form the first cell-layer that has physical and physiological contact with the blastocyst trophectoderm [71]. Under the coordination of E2 and P4, EECs undergo structural and functional changes that establish uterine receptivity [72], which is absolutely necessary for successful embryo implantation in all animals.

To investigate the response of miR-182 expression levels to sex hormones in EECs, E2 and P4 were diluted in cell medium to different concentrations. The expression levels of miR-182 were significantly enhanced in a concentration-dependent manner, with the highest level observed in the presence of P4 alone with 1 nM. This study is the first to our knowledge that the expression levels of miR-182 are affected by sex hormones in the EECs of dairy goats. Thus, the induction of miR-182 may be a critical event for the development of endometrial receptivity, and this induction may be regulated by E2 and P4.

The effect of miR-182 on the surface morphology of EECs

Changes of the luminal epithelial cell surface to facilitate adhesive properties are critical for the attainment of receptivity and successful embryo adhesion [71, 73, 74]. Prior to the receptive phase in the rat uterus, the surface epithelium is characterized by a dense distribution of long, thin microvilli that are covered with a uniform glycocalyx and that are under hormonal control and vary in length and number during the estrous cycle and pregnancy [41]. Based on the above information, the EEC surface morphology was observed by scanning electron microscopy after the cells were transfected with a miR-182 mimics or inhibitors in this study. On the surface of cells treated with miR-182, we observed microridges with uniform and regularly-distributed microvilli. However, cells treated with a miR-182 inhibitors became round, the microvilli on the surface of the cell membrane disappeared, and the cell membrane sprouted (buds) and formed apoptotic bodies (Fig 4). This result suggested that miR-182 may be indispensable for the establishment of endometrial receptivity in dairy goats.

miR-182 regulates proliferation, cell cycle, and apoptosis in EECs

A critical event during embryo implantation is the extensive tissue remodeling at the maternal-fetal interface, characterized by cell proliferation, cell migration and cell adhesion [75, 76]. Integrins, extracellular matrix (ECM) and matrix metalloproteinases (MMPs) are involved in this process and are regulated by the complex endocrine, autocrine and paracrine milieu within the uterus and during cancer [77], and angiogenesis is a common feature of both implantation and cancer spread [78, 79]. Moreover, it is known that miR-182 up-regulated in various cancer type [16, 80, 81], striking similarities are present between the behavior of placental cells during the WOI and that of cancer cells [82]. Nevertheless, the transcriptional regulation of miR-182 as well as its role in EECs during WOI is not clear.

The MTT assay has been widely used to measure the viability and proliferation of cells. In his study, an MTT assay showed that the miR-182 mimics inhibited and miR-182 inhibitors promoted the proliferation of EECs (Fig 5), although the differences were not significant (P > 0.05). Cell proliferation is generally regulated by progression through the cell cycle [42]. Consequently, the disruption of the cell cycle is considered to be a common cause of cell proliferation inhibition [43]. To determine whether the anti-proliferative effect of miR-182 was due to cell cycle disruption, flow cytometry was used to analyze changes in the cell cycle. The distribution of cells in the different phases of the cell cycle did not significantly change after miR-182 exposure in EECs (Fig 6), suggesting that miR-182 does not cause EEC cell cycle arrest under the conditions described.

In addition, an Annexin V-FITC/PI assay combined with flow cytometry 48 h after transfection with miR-182 mimics, miR-182 inhibitors, NC or NC-inhibitors showed that EEC apoptosis (Fig 7) increased upon the introduction of miR-182 mimics compared with NC. The apoptosis rate of EECs treated with a scrambled miR-182 mimics was 15.76%, and this rate decreased to 7.58% upon treatment with miR-182 inhibitors, suggesting that miR-182 induces EEC apoptosis in this study.

miR-182 regulates PTN expression in EECs

Many experiments have confirmed that miRNAs play diverse biological functions by targeting and down-regulating protein levels in animals. For example, Let-7g was reported to target caspase-3 and inhibit the apoptosis induced by oxidized low density lipoprotein (OX-LDL) in endothelial cells [83]. MiRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression [84], miR-21 is overexpressed in response to high glucose and protects endothelial cells from apoptosis by targeting death-domain associated protein [85].

We confirmed the high abundance of miR-182 and the lower levels of PTN in the receptive endometrium of goats and miR-182 directly regulates PTN through its 3′UTR. We further investigated whether miR-182 down-regulated the expression levels of PTN in EECs of dairy goats. And the result showed that overexpression of miR-182 dramatically decreased the mRNA levels of PTN at 48 h; in contrast, miR-182 inhibition increased PTN levels in EECs. WB results further indicated that PTN was down-regulated by miR-182 in dairy goats at 48 h, however, inhibition of PTN protein expression by miR-182 disappeared at 72 h. And the reasoning behind that would be miR-182 mimics used in this study was an artificially synthesized mature miRNA with a shorter effective time; thus, its function may have reduced with time.

miR-182 regulates the phosphorylation of AKT

As a growth factor, PTN could stimulate the cells mitogenesis in culture is dependent on tyrosine kinase activation and utilizes the mitogen-activated protein kinase and the PI3K pathways to transduce a mitogenic signal [51, 86]. Further studies show that PTN could induce the activation of the PI3K/AKT-related pathway in bovine epithelial lens cells [51], glioblastoma cells [87], NIH3T3 fibroblasts [88], and human umbilical vein endothelial cells [89]. Phosphorylated AKT (activated) modulates the activity of a variety of downstream proteins that are related to cell growth, proliferation, apoptosis or differentiation [90, 91]. In addition, inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer [92]. In the present study, miR-182 decreased the expression of total AKT protein levels at both the 48 h and 72 h time points, and the miR-182 inhibitors increased the levels at 72 h (Fig 11A). Meanwhile, miR-182 decreased the p-AKT protein levels at 48 h, and the miR-182 inhibitors increased the levels at both 48 h and 72 h (Fig 11B). In short, these results were in accordance with previous study that reported that knocking down the expression of PTN by small interfering RNA resulted in the reduction of AKT [50].

miR-182 affects the expression of apoptosis-related genes

In mammals, endometrial cells are remodeled by apoptosis, proliferation and differentiation throughout the estrous cycle [93], and apoptosis is an important process in the reconstruction of endometrial receptivity and early implantation of the embryo [94]. An imbalance of pro- and anti-apoptotic events in the secretory endometrium seems to be involved in implantation disorders and consecutive pregnancy complications [95]. What’s more, locally regulated apoptosis of EECs induced by the embryo is a crucial step to facilitate embryo anchorage and access to maternal blood supply in rodents [96] and human [19].

Both the mitochondrial pathway (Bcl-2 family) and the death-receptor system (Fas/FasL) involved in the apoptosis of the endometrium in humans [57, 97, 98] and monkeys [99]. However, no such study has been performed in the EECs of dairy goats. The present report for the first time studies the effect of miR-182 on apoptosis-related proteins (Bcl-2, FAS, and Caspase-3) in the EECs of dairy goats. Bcl-2 family proteins are critical regulators of programmed cell death and act by permeabilizing the mitochondrial outer membrane [100102], and members of the Bcl-2 family can promote or inhibit apoptosis by synthesizing anti-apoptotic (i.e., Bcl-2, Bcl-Xl) or pro-apoptotic (i.e., BAX, BAK, BAD, BID, Bcl-Xs) proteins [103, 104]. In the present study, we found lower levels of BCL-2 protein in the miR-182-treated EECs, suggesting that miR-182 might induce EEC apoptosis by decreasing Bcl-2 expression. Furthermore, the upstream proteins of Bcl-2, MAPK (p44/42) and p-MAPK (p44/42), were also monitored by WB, and these results showed that miR-182 decreased the total MAPK levels at 72 h. Because of their key role in cell signalling, a rigorous regulation of MAPKs is essential in eukaryotic physiology [105], p-MAPKs target different downstream effectors that lead to changes in transcriptional programs [106].

Previous researchers believed there was a relationship of expression between anti- (Bcl2) and pro-apoptotic proteins (Fas, FasL, Bax), although the precise mechanism has not been fully clarified in canine endometrium [107]. Fas (also known as APO-1 or CD95), a tumor necrosis factor (TNF) superfamily receptor, is known to induce apoptotic cell death when it binds to FAS ligand (FasL) [108]. And FAS-mediated apoptosis occurs in the regulation of human endometrial function under hormonal regulation [109]. Further study showed that Fas was localized at the apical cell surface of hEEC, and flow cytometry revealed that 60% of hEECs express Fas [19]. Notably, the expression levels of FAS increased in miR-182 treated EECs at protein levels in dairy goats.

Caspase-3 (also termed CPP32, or apopain) is activated during the early stages of apoptosis [110] and it is the primary executioner of apoptosis, so the expression levels of Caspase-3 is one of the most common used detect indicator to evaluate the apoptosis of many cell types in previous studies [111, 112]. Furthermore, several studies have suggested that endometrial cell death is regulated by Caspase-3 during the menstrual or estrous cycle [113] and during early pregnancy [114]. In this study, we found that the miR-182 mimics increased the Caspase-3 protein levels at 48 h, and miR-182 inhibitors decreased the levels of Caspase-3.

Furthermore, Schulte reported a retroviral SP1 binding site in the PTN promoter is important for the expression in human choriocarcinoma cells [115]. SP1 is a ubiquitously expressed zinc finger protein that regulates the expression of genes by binding to a classical GC box (GGGCGGG),and its binding sites are located distal and/or proximal to the transcription start site of genes [116, 117]. Furthermore, SP1 can also interact with other proteins, such as BPV enhancer E2 protein [118], NF-kB [119], Rb [120], or E2F-1 [121] to contribute to tissue-specific gene regulation. In this study, EECs treated with the miR-182 mimics exhibited an obvious decrease in SP1 expression after 72 h. This result suggested that miR-182 may regulate SP1, but the specific molecular regulation mechanism needs further study.

miR-182 may participate in the formation of endometrial receptivity

OPN has an arginine–glycine–aspartic acid (RGD)-binding site that can bind to the transiently expressed αvβ3 and α4β1 integrin heterodimers [122]. Further study suggested that OPN plays an important role in endometrial receptivity for its consistent up-regulation during the WOI [123]. Thus, we detected the protein levels of OPN in EECs and found that miR-182 significantly increased OPN protein levels in EECs, and the levels decreased after treatment with the miR-182 inhibitors.

In addition, VEGF express in the mouse and rabbit endometrium and participates in the increased angiogenesis and vascular permeability what are necessary for implantation [124, 125]. Deficient expression of VEGF and/or its receptors in mice result in poor development of the vascular network in the endometrium, leading to implantation failures and abortions [126]. Evidence suggests that the expression of VEGF is highly regulated in a temporal and spatial manner at the early stage of implantation [127]. In dairy goats, the VEGF protein levels were down-regulated by the miR-182 mimics, and the miR-182 inhibitors increased VEGF levels in the EECs.

In humans, P4 stimulates decidualization, which first begins in the endometrial stromal cells surrounding the spiral arteries of the uterus during the late secretory phase of the menstrual cycle [128]. At this time, the endometrium begins to undergo remodeling in preparation for embryo implantation. Specifically, the endometrial stromal cells (ESC) undergo a marked rearrangement of the intracellular architecture and begin to accumulate glycogen, initiating the secretion of various proteins, growth factors and cytokines [63], including prolactin (PRL). PRL is one of the strongest decidualization markers [129] involved in regulating endometrial secretory activity in human and rodent, but not in canine [130]. However, it is noteworthy that PRL cannot play important role in the signal transduction cascade without its receptor, PRLR [131]. In this study, the miR-182 mimics did not regulate the protein levels of PRLR in the EECs of dairy goats, but the miR-182 inhibitors down-regulated the levels, suggesting that miR-182 may be an essential factor to keep the expression of PRLR protein levels in the EECs of dairy goats.

Prostaglandin G/H synthase 2 (PTGS2 or COX2) is a rate-limiting enzyme for the synthesis of prostaglandin (PG), which is a critical factor for the maintenances of the uterine environment during early pregnancy [62]. In rodent uterus, COX2-derived PGE2 and PGI2 are the major mediators promoting vascular permeability and decidualization at implantation sites [132]. COX2 knockout mice are infertile, with abnormalities in ovulation, fertilization, implantation, and decidualization [133], and the anti-implantation effect of specific COX2 inhibitors results in decidualization defects [134]. We found that the COX2 protein levels were down-regulated by the miR-182 inhibitors, but the levels changed when the cells were treated with the miR-182 mimics, suggesting that miR-182 may be an essential factor to maintain the expression of COX2 protein levels in dairy goat EECs.

Conclusion

Overall, this study has shown that miR-182 is widely expressed in different tissues in dairy goats and that the expression levels are regulated by E2 and P4 in EECs. We verified for the first time that miR-182 induced EEC apoptosis by directly targeting the 3’ untranslated region of PTN. In addition, miR-182 may be an essential factor for the regulation of the expression of OPN, COX2 and PRLR protein levels in dairy goat EECs. Thus, we conclude the following: miR-182 is up-regulated in the EECs during the WOI, and it induces cell apoptosis by down-regulating the expression of PTN at both mRNA and protein levels; miR-182 plays a role in the development of endometrial receptivity by down-regulating PTN levels and up-regulating or maintaining the expression levels of OPN, COX-2 and PRLR in dairy goat EECs.

Acknowledgments

We would like to acknowledge Prof. Ya-Ping Jin for technical assistance.

Data Availability

All relevant data are within the paper.

Funding Statement

Shaanxi science and technology innovation project plan (2013KTZBO2-02-01), Shaanxi science and technology innovation project plan (2015KTCQ03-08). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Qi X, Qu Y, Nan Z, Jin Y, Zhao X, Wang A. Caprine endometrial stromal cells modulate the effects of steroid hormones on cytokine secretion by endometrial epithelial cells in vitro. Reproductive Biology. 2012;12(3):309–15. doi: 10.1016/j.repbio.2012.09.003 [DOI] [PubMed] [Google Scholar]
  • 2.Bauersachs S, Wolf E. Immune aspects of embryo-maternal cross-talk in the bovine uterus. Journal of Reproductive Immunology. 2013;97(1):20–6. doi: 10.1016/j.jri.2012.11.002 [DOI] [PubMed] [Google Scholar]
  • 3.Gärtner MA, Peter S, Jung M, Drillich M, Einspanier R, Gabler C. Increased mRNA expression of selected pro-inflammatory factors in inflamed bovine endometrium in vivo as well as in endometrial epithelial cells exposed to Bacillus pumilus in vitro. Reproduction Fertility & Development. 2015. [DOI] [PubMed] [Google Scholar]
  • 4.Miravet-Valenciano JA, Rincon-Bertolin A, Vilella F, Simon C. Understanding and improving endometrial receptivity. Current Opinion in Obstetrics & Gynecology. 2015;27(3):187–92. [DOI] [PubMed] [Google Scholar]
  • 5.Gibson DA, Simitsidellis I, Cousins FL, Critchley HOD, Saunders PTK. Intracrine Androgens Enhance Decidualization and Modulate Expression of Human Endometrial Receptivity Genes. Scientific Reports. 2016;6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Creighton CJ, Benham AL, Zhu H, Khan MF, Reid JG, Nagaraja AK, et al. Discovery of novel microRNAs in female reproductive tract using next generation sequencing. Plos One. 2010;5(3):9637. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Cai JL, Liu LL, Hu Y, Jiang XM, Qiu HL, Sha AG, et al. Polychlorinated biphenyls impair endometrial receptivity in vitro via regulating mir-30d expression and epithelial mesenchymal transition. Toxicology. 2016;365:25–34. doi: 10.1016/j.tox.2016.07.017 [DOI] [PubMed] [Google Scholar]
  • 8.Chen C, Zhao Y, Yang Y, Li R, Qiao J. MiR-125b regulates endometrial receptivity by targeting MMP26 in women undergoing IVF-ET with elevated progesterone on HCG priming day. Scientific Reports. 2016;6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Jimenez PT, Mainigi MA, Word RA, Kraus WL, Mendelson CR. miR-200 Regulates Endometrial Development during Early Pregnancy. Molecular endocrinology (Baltimore, Md). 2016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Aylett S. MicroRNAs miR-30b, miR-30d, and miR-494 regulate human endometrial receptivity. Reproductive Sciences. 2013;20(3):308–17. doi: 10.1177/1933719112453507 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Kang YJ, Lees M, Matthews LC, Kimber SJ, Forbes K, Aplin JD. miR-145 suppresses embryo-epithelial juxtacrine communication at implantation by modulating maternal IGF1R. Journal of Cell Science. 2015;128(4):804–14. doi: 10.1242/jcs.164004 [DOI] [PubMed] [Google Scholar]
  • 12.Kouri FM, Hurley LA, Daniel WL, Day ES, Hua Y, Hao L, et al. miR-182 integrates apoptosis, growth, and differentiation programs in glioblastoma. Genes & Development. 2015;29(7):732–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kloosterman WP, Plasterk RH. The Diverse Functions of MicroRNAs in Animal Development and Disease. Developmental Cell. 2006;11(11):441–50. [DOI] [PubMed] [Google Scholar]
  • 14.Xu S, Witmer PD, Lumayag S, Kovacs B, Valle D. MicroRNA (miRNA) transcriptome of mouse retina and identification of a sensory organ-specific miRNA cluster. Journal of Biological Chemistry. 2007;282(282):25053–66. [DOI] [PubMed] [Google Scholar]
  • 15.Wallis CJ, Gordanpour A, Bendavid JS, Sugar L, Nam RK, Seth A. MiR-182 Is Associated with Growth, Migration and Invasion in Prostate Cancer via Suppression of FOXO1. Journal of Cancer. 2015;6(12):1295–305. doi: 10.7150/jca.13176 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Y L, D Z, X W, X Y, C Y, S Z, et al. Hypoxia-inducible miR-182 enhances HIF1α signaling via targeting PHD2 and FIH1 in prostate cancer. Scientific Reports. 2015;5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Du C, Weng X, Hu W, Lv Z, Xiao H, Ding C, et al. Hypoxia-inducible MiR-182 promotes angiogenesis by targeting RASA1 in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 2015;34(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Qu Y, Li WC, Hellem MR, Rostad K, Popa M, Mccormack E, et al. MiR-182 and miR-203 induce mesenchymal to epithelial transition and self-sufficiency of growth signals via repressing SNAI2 in prostate cells. International Journal of Cancer. 2013;133(3):544–55. doi: 10.1002/ijc.28056 [DOI] [PubMed] [Google Scholar]
  • 19.Galán A, O'Connor JE, Valbuena D, Herrer R, Remohí J, Pampfer S, et al. The human blastocyst regulates endometrial epithelial apoptosis in embryonic adhesion. Biology of Reproduction. 2000;63(2):430–9. [DOI] [PubMed] [Google Scholar]
  • 20.Deuel TF, Zhang N, Yeh HJ, Silossantiago I, Wang ZY. Pleiotrophin: a cytokine with diverse functions and a novel signaling pathway. A rchives of Biochemistry & Biophysics. 2002;397(2):162–71. [DOI] [PubMed] [Google Scholar]
  • 21.Pufe T, Bartscher M, Petersen W, Tillmann B, Mentlein R. Pleiotrophin, an embryonic differentiation and growth factor, is expressed in osteoarthritis. Osteoarthritis & Cartilage. 2003;11(4):260–4. [DOI] [PubMed] [Google Scholar]
  • 22.Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Lecture Notes in Control & Information Sciences. 2004;204(2):127–43. [DOI] [PubMed] [Google Scholar]
  • 23.Blondet B, Carpentier G, Lafdil F, Courty J. Pleiotrophin cellular localization in nerve regeneration after peripheral nerve injury. Journal of Histochemistry & Cytochemistry. 2005;53(8):971–7. [DOI] [PubMed] [Google Scholar]
  • 24.Li YS, Milner PG, Chauhan AK, Watson MA, Hoffman RM, Kodner CM, et al. Cloning and expression of a developmentally regulated protein that induces mitogenic and neurite outgrowth activity. Science. 1990;250(4988):1690–4. [DOI] [PubMed] [Google Scholar]
  • 25.Muramatsu T. Midkine and Pleiotrophin: Two Related Proteins Involved in Development, Survival, Inflammation and Tumorigenesis. The Journal of Biochemistry. 2002;132(3):359–71. [DOI] [PubMed] [Google Scholar]
  • 26.Muramatsu H, Peng Z, Kurosawa N, Ichihara-Tanaka K, Maruyama K, Inoh K, et al. Female infertility in mice deficient in midkine and pleiotrophin, which form a distinct family of growth factors. Genes to Cells. 2006;11(12):1405–17. doi: 10.1111/j.1365-2443.2006.01028.x [DOI] [PubMed] [Google Scholar]
  • 27.Mansouriattia N, Aubert J, Reinaud P, Girauddelville C, Taghouti G, Galio L, et al. Gene expression profiles of bovine caruncular and intercaruncular endometrium at implantation. Physiological Genomics. 2009;39(1):14–27. doi: 10.1152/physiolgenomics.90404.2008 [DOI] [PubMed] [Google Scholar]
  • 28.Bany BM, Schultz GA. Pleiotrophin messenger ribonucleic acid levels increase in mouse endometrial stromal cells during decidualization. Endocrinology. 2001;142(2):955–8. doi: 10.1210/endo.142.2.8111 [DOI] [PubMed] [Google Scholar]
  • 29.Johnson GA, Burghardt RC, Joyce MM, Spencer TE, Bazer FW, Pfarrer C, et al. Osteopontin expression in uterine stroma indicates a decidualization-like differentiation during ovine pregnancy. Biology of Reproduction. 2003;68(6):1951–8. doi: 10.1095/biolreprod.102.012948 [DOI] [PubMed] [Google Scholar]
  • 30.Song Y, An X, Zhang L, Fu M, Peng J, Han P, et al. Identification and Profiling of microRNAs in Goat Endometrium during Embryo Implantation. Plos One. 2015;10(4). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Zhang L, An XP, Liu XR, Fu MZ, Han P, Peng JY, et al. Characterization of the Transcriptional Complexity of the Receptive and Pre-receptive Endometria of Dairy Goats. Scientific Reports. 2015;5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang L, An X-P, Liu X-R, Fu M-Z, Han P, Peng J-Y, et al. Characterization of the Transcriptional Complexity of the Receptive and Pre-receptive Endometria of Dairy Goats. Scientific reports. 2015;5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Qi XF, Nan ZC, Jin YP, Qu YY, Zhao XJ, Wang AH. Stromal-epithelial interactions modulate the effect of ovarian steroids on goat uterine epithelial cell interleukin-18 release. Domestic Animal Endocrinology. 2012;42(4):210–9. doi: 10.1016/j.domaniend.2011.12.004 [DOI] [PubMed] [Google Scholar]
  • 34.Li Z, Lan X, Guo W, Sun J, Huang Y, Wang J, et al. Comparative Transcriptome Profiling of Dairy Goat MicroRNAs from Dry Period and Peak Lactation Mammary Gland Tissues. Plos One. 2012;7(12):5806–19. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Sun X, He Y, Ma T-T, Huang C, Zhang L, Li J. Participation of miR-200a in TGF-β1-mediated hepatic stellate cell activation. Molecular and cellular biochemistry. 2014;388(1–2):11–23. doi: 10.1007/s11010-013-1895-0 [DOI] [PubMed] [Google Scholar]
  • 36.Gu Y, Wang Y, Zhou Q, Bowman L, Mao G, Zou B, et al. Inhibition of Nickel Nanoparticles-Induced Toxicity by Epigallocatechin-3-Gallate in JB6 Cells May Be through Down-Regulation of the MAPK Signaling Pathways. Plos One. 2016;11(3). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Gu Y, Wang XD, Lu JJ, Lei YY, Zou JY, Luo HH. Effect of mir-16 on proliferation and apoptosis in human A549 lung adenocarcinoma cells. International Journal of Clinical & Experimental Medicine. 2015;8(3):3227–33. [PMC free article] [PubMed] [Google Scholar]
  • 38.Chen C, Yan Q, Liu K, Zhou X, Xian Y, Liang D, et al. Endometrial Receptivity Markers in Mice Stimulated With Raloxifene Versus Clomiphene Citrate and Natural Cycles. Reproductive Sciences. 2015;120(11):1297–304. [DOI] [PubMed] [Google Scholar]
  • 39.Zhao H, Zhang T, Xia C, Shi L, Wang S, Zheng X, et al. Berberine ameliorates cartilage degeneration in interleukin-1β-stimulated rat chondrocytes and in a rat model of osteoarthritis via Akt signalling. Journal of Cellular & Molecular Medicine. 2014;18(2):283–92. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Subramaniam KS, Omar IS, Kwong SC, Mohamed Z, Woo YL, Mat Adenan NA, et al. Cancer-associated fibroblasts promote endometrial cancer growth via activation of interleukin-6/STAT-3/c-Myc pathway. American Journal of Cancer Research. 2016;6(2):200–13. [PMC free article] [PubMed] [Google Scholar]
  • 41.Rp RDC, Serrão PM, Monteiro S, Pessa P, Silva JR, Ferreira-Dias G. Caspase-3-mediated apoptosis and cell proliferation in the equine endometrium during the oestrous cycle. Reproduction Fertility & Development. 2007;19(8):925–32. [DOI] [PubMed] [Google Scholar]
  • 42.Kuo HP, Lee YJ, Hsu CY, Lee SL, Hsu SC, Chuang TC, et al. Growth-suppressive effect of berberine on endometrial carcinoma cells: Role of mitochondrial and PI3K/Akt pathway. Journal of Functional Foods. 2015;17:600–9. [Google Scholar]
  • 43.Greenbaum LE. Cell cycle regulation and hepatocarcinogenesis. Cancer Biology & Therapy. 2005;3(12):1200–7. [DOI] [PubMed] [Google Scholar]
  • 44.Chung HW, Wen Y, Choi EA, Hao-Li, Moon HS, Yu HK, et al. Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. MHR: Basic science of reproductive medicine. 2002;8(4):350–5. [DOI] [PubMed] [Google Scholar]
  • 45.Brigstock DR, Kim GY, Steffen CL. Pig uterine luminal fluid contains the developmentally regulated neurotrophic factor, pleiotrophin. Journal of Endocrinology. 1996;148(1):103–11. [DOI] [PubMed] [Google Scholar]
  • 46.Vanderwinden JM, Mailleux P, Schiffmann SN, Vanderhaeghen JJ. Cellular distribution of the new growth factor pleiotrophin (HB-GAM) mRNA in developing and adult rat tissues. Brain Structure and Function. 1992;186(4):387–406. [DOI] [PubMed] [Google Scholar]
  • 47.Silossantiago I, Yeh HJ, Gurrieri MA, Guillerman RP, Li YS, Wolf J, et al. Localization of pleiotrophin and its mRNA in subpopulations of neurons and their corresponding axonal tracts suggests important roles in neural-glial interactions during development and in maturity. Developmental Neurobiology. 1996;31(3):283–96. [DOI] [PubMed] [Google Scholar]
  • 48.Vacherot F, Laaroubi K, Caruelle D, Delbe J, Barritault D, Caruelle JP, et al. Upregulation of heparin-affin regulatory peptide by androgen. In Vitro Cellular & Developmental Biology—Animal. 1995;31(9):647–8. [DOI] [PubMed] [Google Scholar]
  • 49.Vivanco I, Sawyers CL. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nature Reviews Cancer. 2002;2(2):489–501. [DOI] [PubMed] [Google Scholar]
  • 50.Li G, Hu Y, Huo Y, Liu M, Freeman D, Gao J, et al. PTEN deletion leads to up-regulation of a secreted growth factor pleiotrophin. Journal of Biological Chemistry. 2006;281(16):10663–8. doi: 10.1074/jbc.M512509200 [DOI] [PubMed] [Google Scholar]
  • 51.Souttou B, Ahmad S, Riegel AT, Wellstein A. Signal transduction pathways involved in the mitogenic activity of pleiotrophin. Implication of mitogen-activated protein kinase and phosphoinositide 3-kinase pathways. Journal of Biological Chemistry. 1997;272(31):19588–93. [DOI] [PubMed] [Google Scholar]
  • 52.Gu D, Yu B, Zhao C, Ye W, Lv Q, Hua Z, et al. The effect of pleiotrophin signaling on adipogenesis. Febs Letters. 2007;581(3):382–8. doi: 10.1016/j.febslet.2006.12.043 [DOI] [PubMed] [Google Scholar]
  • 53.Wasowska B, Ludkiewicz B, Stefańczyk-Krzymowska S, Grzegorzewski W, Skipor J. Apoptotic cell death in the porcine endometrium during the oestrous cycle. Acta Veterinaria Hungarica. 2001;49(1):71–9. [DOI] [PubMed] [Google Scholar]
  • 54.Chu PY, Lee CS, Wright PJ. Degeneration and apoptosis of endometrial cells in the bitch. Theriogenology. 2006;66(6–7):1545–9. doi: 10.1016/j.theriogenology.2006.01.018 [DOI] [PubMed] [Google Scholar]
  • 55.Cruchten SV, Broeck WVD, Duchateau L, Simoens P. Apoptosis in the canine endometrium during the estrous cycle. Theriogenology. 2003;60(9):1595–608. [DOI] [PubMed] [Google Scholar]
  • 56.Nawaz S, Lynch MP, Galand P, Gerschenson LE. Hormonal regulation of cell death in rabbit uterine epithelium. American Journal of Pathology. 1987;127(1):51–9. [PMC free article] [PubMed] [Google Scholar]
  • 57.Harada T, Kaponis A, Iwabe T, Taniguchi F, Makrydimas G, Sofikitis N, et al. Apoptosis in human endometrium and endometriosis. Human Reproduction Update. 2004;10(1):29–38. [DOI] [PubMed] [Google Scholar]
  • 58.Cha J, Vilella F, Dey SK, Simon C. Molecular Interplay in Successful Implantation in Ten Critical Topics in Reproductive Medicine—A Sponsored Supplement to Science. 2013.
  • 59.Miravet-Valenciano JA, Rincon-Bertolin A, Vilella F, Simon C. Understanding and improving endometrial receptivity. Current Opinion in Obstetrics & Gynecology. 2015;27(3). [DOI] [PubMed] [Google Scholar]
  • 60.Talbi S, Hamilton AE, Vo KC, Tulac S, Overgaard MT, Dosiou C, et al. Molecular phenotyping of human endometrium distinguishes menstrual cycle phases and underlying biological processes in normo-ovulatory women. Endocrinology. 2006;147(3):1097–121. doi: 10.1210/en.2005-1076 [DOI] [PubMed] [Google Scholar]
  • 61.Kaufmann P, Mayhew TM, Charnock-Jones DS. Aspects of Human Fetoplacental Vasculogenesis and Angiogenesis. II. Changes During Normal Pregnancy. Placenta. 2004;25(2–3):114–26. doi: 10.1016/j.placenta.2003.10.009 [DOI] [PubMed] [Google Scholar]
  • 62.Isayama K, Zhao L, Chen H, Yamauchi N, Shigeyoshi Y, Hashimoto S, et al. Removal of Rev-erbα inhibition contributes to the prostaglandin G/H synthase 2 expression in rat endometrial stromal cells. Ajp Endocrinology & Metabolism. 2015;308(8):2462–7. [DOI] [PubMed] [Google Scholar]
  • 63.Zhang D, Dong C, Tao L, Zhang Y, Chen ZJ, Cong Z. Dysfunction of Liver Receptor Homolog-1 in Decidua: Possible Relevance to the Pathogenesis of Preeclampsia. Plos One. 2015;10(12). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Tamura I, Sato S, Okada M, Tanabe M, Lee L, Maekawa R, et al. Importance of C/EBPβ binding and histone acetylation status in the promoter regions for induction of IGFBP-1, PRL, and Mn-SOD by cAMP in human endometrial stromal cells. Endocrinology. 2014;155(1):275–86. doi: 10.1210/en.2013-1569 [DOI] [PubMed] [Google Scholar]
  • 65.Vilella F, Ramirez L, Berlanga O, Martínez S, Alamá P, Meseguer M, et al. PGE2 and PGF2α concentrations in human endometrial fluid as biomarkers for embryonic implantation. Journal of Clinical Endocrinology & Metabolism. 2013;98(10):4123–32. [DOI] [PubMed] [Google Scholar]
  • 66.Creighton CJ, Benham AL, Zhu H, Khan MF, Reid JG, Nagaraja AK, et al. Discovery of novel microRNAs in female reproductive tract using next generation sequencing. PloS one. 2010;5(3):e9637 doi: 10.1371/journal.pone.0009637 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67.Chen J, Gu L, Ni J, Hu P, Hu K, Shi YL. MiR-183 Regulates ITGB1P Expression and Promotes Invasion of Endometrial Stromal Cells. Biomed Research International. 2015;2015(13). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.SJ H, G R, JL L, ZA Z, YS Y, RW S, et al. MicroRNA expression and regulation in mouse uterus during embryo implantation. Journal of Biological Chemistry. 2008;283(34):23473–84. doi: 10.1074/jbc.M800406200 [DOI] [PubMed] [Google Scholar]
  • 69.Wei Q, Lei R, Hu G. Roles of miR-182 in sensory organ development and cancer. Thoracic Cancer. 2015;6(1):2–9. doi: 10.1111/1759-7714.12164 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Lin R, Shen W, Zhi Y, Zhou Z. Prognostic value of miR-26a and HMGA1 in urothelial bladder cancer. Biomedicine & Pharmacotherapy. 2014;68(8):929–34. [DOI] [PubMed] [Google Scholar]
  • 71.Murphy CR. Uterine receptivity and the plasma membrane transformation. Cell Research. 2004;14(4):259–67. doi: 10.1038/sj.cr.7290227 [DOI] [PubMed] [Google Scholar]
  • 72.Zhang S, Kong S, Lu J, Wang Q, Chen Y, Wang W, et al. Deciphering the molecular basis of uterine receptivity. Molecular Reproduction & Development. 2013;80(1):8–21. [DOI] [PubMed] [Google Scholar]
  • 73.Thie M, Denker HW. In vitro Studies on Endometrial Adhesiveness for Trophoblast: Cellular Dynamics in Uterine Epithelial Cells. Cells Tissues Organs. 2002;172(3):237–52. [DOI] [PubMed] [Google Scholar]
  • 74.Van SM, Oyanedel J, Menkhorst E, Cuman C, Rainczuk K, Winship A, et al. Soluble Delta-like ligand 1 alters human endometrial epithelial cell adhesive capacity. Reproduction Fertility & Development. 2015. [DOI] [PubMed] [Google Scholar]
  • 75.Tranguch S, Dey SK. A lifetime of deciphering complexities of embryo implantation. Int J Dev Biol. 2014;58:79–86. doi: 10.1387/ijdb.130332st [DOI] [PubMed] [Google Scholar]
  • 76.Hu S-J, Ren G, Liu J-L, Zhao Z-A, Yu Y-S, Su R-W, et al. MicroRNA expression and regulation in mouse uterus during embryo implantation. Journal of Biological Chemistry. 2008;283(34):23473–84. doi: 10.1074/jbc.M800406200 [DOI] [PubMed] [Google Scholar]
  • 77.Albelda SM, Buck CA. Integrins and other cell adhesion molecules. The FASEB Journal. 1990;4(11):2868–80. [PubMed] [Google Scholar]
  • 78.Albini A, Benelli R. The chemoinvasion assay: a method to assess tumor and endothelial cell invasion and its modulation. Nature Protocol. 2007;48(2):504–11. [DOI] [PubMed] [Google Scholar]
  • 79.Murray MJ, Lessey BA. Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Seminars in Reproductive Endocrinology. 1999;17(3):275–90. doi: 10.1055/s-2007-1016235 [DOI] [PubMed] [Google Scholar]
  • 80.Lei R, Tang J, Zhuang X, Deng R, Li G, Yu J, et al. Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis. Oncogene. 2013;33(10):1287–96. doi: 10.1038/onc.2013.65 [DOI] [PubMed] [Google Scholar]
  • 81.Mihelich BL, Khramtsova EA, Arva N, Vaishnav A, Johnson DN, Giangreco AA, et al. miR-183-96-182 cluster is overexpressed in prostate tissue and regulates zinc homeostasis in prostate cells. Journal of Biological Chemistry. 2011;286(52):44503–11. doi: 10.1074/jbc.M111.262915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Horikoshi Y, Matsumoto H, Takatsu Y, Ohtaki T, Kitada C, Usuki S, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. The Journal of Clinical Endocrinology & Metabolism. 2003;88(2):914–9. [DOI] [PubMed] [Google Scholar]
  • 83.Zhang Y, Chen N, Zhang J, Tong Y. Hsa-let-7g miRNA targets caspase-3 and inhibits the apoptosis induced by ox-LDL in endothelial cells. International Journal of Molecular Sciences. 2013;14(11):22708–20. doi: 10.3390/ijms141122708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Zhu HQ, Li Q, Dong LY, Zhou Q, Wang H, Wang Y. MicroRNA-29b promotes high-fat diet-stimulated endothelial permeability and apoptosis in apoE knock-out mice by down-regulating MT1 expression. International Journal of Cardiology. 2014;176(3):764–70. doi: 10.1016/j.ijcard.2014.07.095 [DOI] [PubMed] [Google Scholar]
  • 85.Zeng J, Xiong Y, Li G, Liu M, He T, Tang Y, et al. MiR-21 is overexpressed in response to high glucose and protects endothelial cells from apoptosis. Experimental & Clinical Endocrinology & Diabetes. 2013;121(7):425–30. [DOI] [PubMed] [Google Scholar]
  • 86.Vacherot F, Delbé J, Caruelle D. Biochemical and mitogenic properties of the heparin-binding growth factor HARP. Progress in Growth Factor Research. 1995;6(1):25–34. [DOI] [PubMed] [Google Scholar]
  • 87.Powers C, Aigner A, Stoica GE, Mcdonnell K, Wellstein A. Pleiotrophin signaling through anaplastic lymphoma kinase is rate-limiting for glioblastoma growth. Journal of Biological Chemistry. 2002;277(16):14153–8. doi: 10.1074/jbc.M112354200 [DOI] [PubMed] [Google Scholar]
  • 88.Bowden ET, Stoica GE, Wellstein A. Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase. Journal of Biological Chemistry. 2002;277(39):35862–8. doi: 10.1074/jbc.M203963200 [DOI] [PubMed] [Google Scholar]
  • 89.Souttou B, Raulais D, Vigny M. Pleiotrophin induces angiogenesis: involvement of the phosphoinositide-3 kinase but not the nitric oxide synthase pathways. Journal of Cellular Physiology. 2001;187(1):59–64. doi: 10.1002/1097-4652(2001)9999:9999<00::AID-JCP1051>3.0.CO;2-F [DOI] [PubMed] [Google Scholar]
  • 90.Kanamori Y, Kigawa J, Itamochi H, Shimada M, Takahashi M, Kamazawa S, et al. Correlation between loss of PTEN expression and Akt phosphorylation in endometrial carcinoma. Clinical Cancer Research. 2001;7(4):892–5. [PubMed] [Google Scholar]
  • 91.Podsypanina K, Parsons R. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. Proceedings of the National Academy of Sciences of the United States of America. 1999;96(4):1563–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92.Gu C, Zhang Z, Yu Y, Liu Y, Zhao F, Yin L, et al. Inhibiting the PI3K/Akt pathway reversed progestin resistance in endometrial cancer. Cancer Science. 2011;102(3):557–64. doi: 10.1111/j.1349-7006.2010.01829.x [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Arai M, Yoshioka S, Nishimura R, Okuda K. FAS/FASL-mediated cell death in the bovine endometrium. Animal Reproduction Science. 2014;151(3–4):97–104. doi: 10.1016/j.anireprosci.2014.10.004 [DOI] [PubMed] [Google Scholar]
  • 94.Antsiferova YS, Sotnikova NY. Apoptosis and endometrial receptivity: Relationship with in vitro fertilization treatment outcome. World Journal of Obstetrics & Gynecology. 2016;5(1). [Google Scholar]
  • 95.Fluhr H, Spratte J, Bredow M, Heidrich S, Zygmunt M. Constitutive activity of Erk1/2 and NF-κB protects human endometrial stromal cells from death receptor-mediated apoptosis. Reproductive Biology. 2013;13(2):113–21. doi: 10.1016/j.repbio.2013.03.001 [DOI] [PubMed] [Google Scholar]
  • 96.Pampfer S, Donnay I. Apoptosis at the time of embryo implantation in mouse and rat. Cell Death & Differentiation. 1999;6(6):533–45. [DOI] [PubMed] [Google Scholar]
  • 97.Otsuki Y. Apoptosis in human endometrium: apoptotic detection methods and signaling. Medical Electron Microscopy Official Journal of the Clinical Electron Microscopy Society of Japan. 2001;34(3):166–73. doi: 10.1007/s007950100011 [DOI] [PubMed] [Google Scholar]
  • 98.Tao XJ, Tilly KI, Maravei DV, Shifren JL, Krajewski S, Reed JC, et al. Differential expression of members of the bcl-2 gene family in proliferative and secretory human endometrium: glandular epithelial cell apoptosis is associated with increased expression of bax. Journal of Clinical Endocrinology & Metabolism. 1997;82(8):2738–46. [DOI] [PubMed] [Google Scholar]
  • 99.Wei P, Jin X, Tao SX, Han CS, Liu YX. Fas, FasL, Bcl-2, and Bax in the endometrium of rhesus monkey during the menstrual cycle. Molecular Reproduction & Development. 2005;70(4):478–84. [DOI] [PubMed] [Google Scholar]
  • 100.Gillies LA, Kuwana T. Apoptosis Regulation at the Mitochondrial Outer Membrane. Journal of Cellular Biochemistry. 2014;115(4):632–40. doi: 10.1002/jcb.24709 [DOI] [PubMed] [Google Scholar]
  • 101.Eissing T, Waldherr S, Allgöwer F, Scheurich P, Bullinger E. Response to Bistability in Apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores. Biophysical Journal. 2007;92(9):3332–4. doi: 10.1529/biophysj.106.100362 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Bagci EZ, Vodovotz Y, Billiar TR, Ermentrout GB, Bahar I. Bistability in Apoptosis: Roles of Bax, Bcl-2, and Mitochondrial Permeability Transition Pores. Biophysical Journal. 2006;90(5):1546–59. doi: 10.1529/biophysj.105.068122 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103.Antonsson B, Martinou JC. The Bcl-2 Protein Family. Experimental Cell Research. 2000;256(1):50–7. doi: 10.1006/excr.2000.4839 [DOI] [PubMed] [Google Scholar]
  • 104.Dorjgochoo T, Xiang YB, Long J, Shi J, Deming S, Xu WH, et al. Association of Genetic Markers in the BCL-2 Family of Apoptosis-Related Genes with Endometrial Cancer Risk in a Chinese Population. Plos One. 2013;8(4):e60915–e. doi: 10.1371/journal.pone.0060915 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 105.Martín H, Flández M, Nombela C, Molina M. Protein phosphatases in MAPK signalling: we keep learning from yeast. Molecular Microbiology. 2005;58(1):6–16. doi: 10.1111/j.1365-2958.2005.04822.x [DOI] [PubMed] [Google Scholar]
  • 106.Yoon S, Seger R. The extracellular signal-regulated kinase: Multiple substrates regulate diverse cellular functions. Growth Factors. 2006;24(1):21–44. doi: 10.1080/02699050500284218 [DOI] [PubMed] [Google Scholar]
  • 107.Henriques S, Silva E, Cruz S, Silva MF, Ferreiradias G, Lopesdacosta L, et al. Oestrous cycle-dependent expression of Fas and Bcl2 family gene products in normal canine endometrium. Reproduction Fertility & Development. 2015. [DOI] [PubMed] [Google Scholar]
  • 108.Nagata S. Fas ligand-induced apoptosis. Annual Review of Genetics. 1999;33(4):29–55. [DOI] [PubMed] [Google Scholar]
  • 109.Song J, Rutherford T, Naftolin F, Brown S, Mor G. Hormonal regulation of apoptosis and the Fas and Fas ligand system in human endometrial cells. Molecular Human Reproduction. 2002;8(5):447–55. [DOI] [PubMed] [Google Scholar]
  • 110.Alan E, Liman N. Involution dependent changes in distribution and localization of bax, survivin, caspase-3, and calpain-1 in the rat endometrium. Microscopy Research & Technique. 2016;79(4):285–97. [DOI] [PubMed] [Google Scholar]
  • 111.Jin Z, El-Deiry WS. Overview of cell death signaling pathways. Cancer Biology & Therapy. 2005;4(2):147–71. [DOI] [PubMed] [Google Scholar]
  • 112.Gown AM, Willingham MC. Improved detection of apoptotic cells in archival paraffin sections: immunohistochemistry using antibodies to cleaved caspase 3. Journal of Histochemistry & Cytochemistry Official Journal of the Histochemistry Society. 2002;50(4):449–54. [DOI] [PubMed] [Google Scholar]
  • 113.Arai M, Yoshioka S, Tasaki Y, Okuda K. Remodeling of bovine endometrium throughout the estrous cycle. Animal Reproduction Science. 2013;142(1–2):1–9. doi: 10.1016/j.anireprosci.2013.08.003 [DOI] [PubMed] [Google Scholar]
  • 114.Oner H, Oner J, Demir R. Distribution of PCNA and Cas-3 in rat uterus during early pregnancy. Folia Histochemica Et Cytobiologica. 2010;48(1):71–7. doi: 10.2478/v10042-008-0088-2 [DOI] [PubMed] [Google Scholar]
  • 115.Schulte AM, Malerczyk C, Cabal-Manzano R, Gajarsa JJ, List HJ, Riegel AT, et al. Influence of the human endogenous retrovirus-like element HERV-E.PTN on the expression of growth factor pleiotrophin: a critical role of a retroviral Sp1-binding site. Oncogene. 2000;19(35):3988–98. doi: 10.1038/sj.onc.1203742 [DOI] [PubMed] [Google Scholar]
  • 116.Suske G. The Sp-family of transcription factors. Gene. 1999;238(238):291–300. [DOI] [PubMed] [Google Scholar]
  • 117.Nuchprayoon I, Shang J, Simkevich CP, Luo M, Rosmarin AG, Friedman AD. An enhancer located between the neutrophil elastase and proteinase 3 promoters is activated by Sp1 and an Ets factor. Journal of Biological Chemistry. 1999;274(2):1085–91. [DOI] [PubMed] [Google Scholar]
  • 118.Li R, Knight JD, Jackson SP, Tjian R, Botchan MR. Direct interaction between Sp1 and the BPV enhancer E2 protein mediates synergistic activation of transcription. Cell. 1991;65(3):493–505. [DOI] [PubMed] [Google Scholar]
  • 119.Perkins ND, Edwards NL, Duckett CS, Agranoff AB, Schmid RM, Nabel GJ. A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. Embo Journal. 1993;12(9):3551–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 120.Udvadia AJ, Templeton DJ, Horowitz JM. Functional interactions between the retinoblastoma (Rb) protein and Sp-family members: superactivation by Rb requires amino acids necessary for growth suppression. Proceedings of the National Academy of Sciences. 1995;92(9):3953–7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 121.Lin SY, Black AR, Kostic D, Pajovic S, Hoover CN, Azizkhan JC. Cell cycle-regulated association of E2F1 and Sp1 is related to their functional interaction. Molecular & Cellular Biology. 1996;16(4):1668–75. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Lessey BA, Castelbaum AJ, Buck CA, Lei Y, Yowell CW, Sun J. Further characterization of endometrial integrins during the menstrual cycle and in pregnancy * †. Fertility & Sterility. 1994;62(3):497–506. [PubMed] [Google Scholar]
  • 123.Horcajadas JA, Anne R, Francisco D, Ana C, Antonio P, Carlos S. Determinants of endometrial receptivity. Annals of the New York Academy of Sciences. 2005;1034(1):166–75. [DOI] [PubMed] [Google Scholar]
  • 124.Das SK, Chakraborty I, Wang J, Dey SK, Hoffman LH. Expression of vascular endothelial growth factor (VEGF) and VEGF-receptor messenger ribonucleic acids in the peri-implantation rabbit uterus. Biology of Reproduction. 1997;56(6):1390–9. [DOI] [PubMed] [Google Scholar]
  • 125.Chakraborty I, Das SK, Dey SK. Differential expression of vascular endothelial growth factor and its receptor mRNAs in the mouse uterus around the time of implantation. Journal of Endocrinology. 1995;147(2):339–52. [DOI] [PubMed] [Google Scholar]
  • 126.Evans PW, Wheeler T, Anthony FW, Osmond C. A longitudinal study of maternal serum vascular endothelial growth factor in early pregnancy. Human Reproduction. 1998;13(4):1057–62. [DOI] [PubMed] [Google Scholar]
  • 127.Demir R, Yaba A, Huppertz B. Vasculogenesis and angiogenesis in the endometrium during menstrual cycle and implantation. Acta Histochemica. 2010;112(3):203–14. doi: 10.1016/j.acthis.2009.04.004 [DOI] [PubMed] [Google Scholar]
  • 128.Maruyama T, Yoshimura Y. Molecular and cellular mechanisms for differentiation and regeneration of the uterine endometrium. Endocrine Journal. 2008;55(55):795–810. [DOI] [PubMed] [Google Scholar]
  • 129.Ganeff C, Chatel G, Munaut C, Frankenne F, Foidart JM, Winkler R. The IGF system in in-vitro human decidualization. Molecular Human Reproduction. 2009;15(1):27–38. doi: 10.1093/molehr/gan073 [DOI] [PubMed] [Google Scholar]
  • 130.Jabbour HN, Critchley HO, Boddy SC. Expression of Functional Prolactin Receptors in Nonpregnant Human Endometrium: Janus Kinase-2, Signal Transducer and Activator of Transcription-1 (STAT1), and STAT5 Proteins Are Phosphorylated after Stimulation with Prolactin. Journal of Clinical Endocrinology & Metabolism. 1998;83(7):2545–53. [DOI] [PubMed] [Google Scholar]
  • 131.Wilkanowska A, Mazurowski A, Mroczkowski S, Kokoszyński D. Prolactin (PRL) and prolactin receptor (PRLR) genes and their role in poultry production traits. Folia Biologica. 2014;62(1):1–8. [DOI] [PubMed] [Google Scholar]
  • 132.Kennedy TG, Gilliomeina C, Phang SH. Prostaglandins and the initiation of blastocyst implantation and decidualization. Reproduction. 2007;134(5):635–43. doi: 10.1530/REP-07-0328 [DOI] [PubMed] [Google Scholar]
  • 133.Lim H, Paria BC, Das SK, Dinchuk JE, Langenbach R, Trzaskos JM, et al. Multiple female reproductive failures in cyclooxygenase 2-deficient mice. Cell. 1997;91(2):197–208. [DOI] [PubMed] [Google Scholar]
  • 134.Sookvanichsilp N, Pulbutr P. Anti-implantation effects of indomethacin and celecoxib in rats. Contraception. 2002;65(5):373–8. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

All relevant data are within the paper.


Articles from PLoS ONE are provided here courtesy of PLOS

RESOURCES